SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-19-000288
Filing Date
2019-01-15
Accepted
2019-01-15 16:10:15
Documents
14
Period of Report
2019-01-15

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_011519.htm 6-K 13024
2 EXHIBIT 99.1 exh_991.htm EX-99.1 18786
3 GRAPHIC exh991_01.jpg GRAPHIC 78522
4 GRAPHIC exh991_02.jpg GRAPHIC 138853
5 GRAPHIC exh991_03.jpg GRAPHIC 73304
6 GRAPHIC exh991_04.jpg GRAPHIC 69887
7 GRAPHIC exh991_05.jpg GRAPHIC 82664
8 GRAPHIC exh991_06.jpg GRAPHIC 116343
9 GRAPHIC exh991_07.jpg GRAPHIC 103709
10 GRAPHIC exh991_08.jpg GRAPHIC 65646
11 GRAPHIC exh991_09.jpg GRAPHIC 70106
12 GRAPHIC exh991_10.jpg GRAPHIC 48746
13 GRAPHIC exh991_11.jpg GRAPHIC 38254
14 GRAPHIC exh991_12.jpg GRAPHIC 106145
  Complete submission text file 0001171843-19-000288.txt   1394198
Mailing Address OSTERGADE 24A, 1 COPENHAGEN G7 1100
Business Address OSTERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242
Forward Pharma A/S (Filer) CIK: 0001604924 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36686 | Film No.: 19527225
SIC: 2834 Pharmaceutical Preparations